Abiraterone-induced rhabdomyolysis: A case report
2016 ◽
Vol 23
(2)
◽
pp. 148-151
◽
Keyword(s):
Abiraterone is an inhibitor of androgen biosynthesis indicated for the treatment of metastatic castration-resistant prostate cancer. Common side effects include diarrhea, edema, hypokalemia, hypertension, and liver function test abnormalities. We report a case of rhabdomyolysis developing in association with the use of abiraterone. Following discontinuation of abiraterone, creatine kinase concentrations decreased gradually throughout the duration of the hospitalization.
2019 ◽
Vol 17
(2)
◽
pp. 157-160
◽
Keyword(s):
2016 ◽
Vol 14
(5)
◽
pp. e529-e533
◽
2013 ◽
Vol 17
◽
pp. S7-S12
◽
2019 ◽
Vol 17
(1)
◽
pp. e61-e64
◽